Big pharma has been none too shy about backing away from biotech deals lately, as the likes of Rigel Pharmaceuticals Inc., Targacept Inc., Metabolex Inc., S*BIO Pte Ltd., Portola Pharmaceuticals Inc., Renovo plc, Arena Pharmaceuticals Inc., Adolor Corp. and others…
Join the Conversation